Related Experiment Video
Updated: Jun 29, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
Evaluation of the Levels of Selected Cytokines and Their Possible Influence on the Development of Cardiovascular and
Anita Stanjek-Cichoracka1,2, Jacek T Niedziela3,4, Anna Łaszewska2
1Department of Biophysics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jedności 8, 41-200 Sosnowiec, Poland.
This study found no direct link between cytokine levels and cardiovascular/pulmonary issues post-COVID-19. However, elevated levels of certain cytokines in survivors warrant further monitoring for potential long-term health concerns.
Area of Science:
- Immunology
- Cardiology
- Pulmonology
- Infectious Diseases
Background:
- COVID-19 survivors may develop cardiovascular and pulmonary complications.
- Cytokines play a role in inflammatory and disease processes.
- Understanding post-COVID-19 immune responses is crucial for managing long-term health.
Purpose of the Study:
- To evaluate selected cytokine levels in COVID-19 survivors.
- To investigate the influence of these cytokines on cardiovascular and pulmonary complications.
- To assess potential correlations in patients hospitalized at the Silesian Centre for Heart Disease.
Main Methods:
- Analysis of 76 COVID-19 survivors from the SILCOVID-19 database.
- Measurement of 30 serum cytokines using Luminex100 platform and Milliplex MAP kit.
- Data collected a median of 102 days post-symptom onset.
Main Results:
- No significant differences in most cytokine levels were found between patients with or without lung/cardiac abnormalities.
- Cytokine concentrations did not significantly differ based on gender, age, comorbidities, or psychological disorders.
- Elevated levels of platelet-derived growth factor-AA (PDGF-AA), monocyte chemoattractant protein-1 (MCP-1), monokine-induced gamma interferon (MIG), and vascular endothelial growth factor-A (VEGF-A) were observed.
Conclusions:
- No direct association was found between the studied cytokines and the incidence of cardiovascular/pulmonary complications in COVID-19 survivors.
- High levels of cytokines like PDGF-AA, VEGF, MIG, IP10 (lung disease relevance), and MCP-1 (cardiovascular disease relevance) are concerning in this cohort.
- Continued monitoring of cytokine levels and diagnostic imaging is recommended for early detection and management of potential abnormalities in COVID-19 survivors.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

